ARRAY BIOPHARMA INC - NOTE 2.625%12/0

CUSIP: 04269XAB1

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Debt / NOTE 2.625%12/0
Market price (% of par)
120.86%
Total 13F principal
$120,060,000
Principal change
+$1,510,000
Total reported market value
$159,424,000
Number of holders
17
Value change
+$1,879,011
Number of buys
6
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 04269XAB1?
CUSIP 04269XAB1 identifies 04269XAB1 - ARRAY BIOPHARMA INC - NOTE 2.625%12/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ARRAY BIOPHARMA INC - NOTE 2.625%12/0 as of Q4 2018

As of 31 Dec 2018, ARRAY BIOPHARMA INC - NOTE 2.625%12/0 was held by 17 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $120,060,000 in principal (par value) of the bond. The largest 10 bondholders included Linden Advisors LP, Redmile Group, LLC, DEUTSCHE BANK AG\, DeepCurrents Investment Group LLC, Graham Capital Management, L.P., TENOR CAPITAL MANAGEMENT Co., L.P., CSS LLC/IL, CITADEL ADVISORS LLC, Verition Fund Management LLC, and AMERIPRISE FINANCIAL INC. This page lists 17 institutional bondholders reporting positions for the Q4 2018 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.